NCT06856512

Brief Summary

The aim of this clinical trial is to evaluate whether intermittent exercise and remote ischaemic preconditioning (rIPC) during haemodialysis (HD) can provide cardioprotection in adult patients (aged 20-79 years) undergoing HD for at least 3 months. The main questions to be answered are Does intermittent exercise or rIPC reduce myocardial stunning during HD? Do these interventions have a beneficial effect on haemorheology, arrhythmias, systemic inflammation and HD efficiency? The investigators will compare three HD sessions: no intervention (HD-CONT), with moderate-intensity intermittent exercise (HD-EX), and with rIPC using cuff inflation (HD-rIPC) to see if HD6EX and HD-rIPC approaches offer enhanced cardioprotection. Participants will: Undergo three randomised HD sessions. Participate in 5 blocks of moderate-intensity exercise or rIPC during the HD sessions. Have cardiac function and biomarkers assessed before, during and after HD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 5, 2025

Completed
12 days until next milestone

Study Start

First participant enrolled

February 17, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

March 4, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 26, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 26, 2025

Completed
Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

4 months

First QC Date

February 5, 2025

Last Update Submit

April 28, 2026

Conditions

Keywords

Hemodialysismyocardial functionexerciseremote ischemic preconditioningmyocardial stunningcardioprotection

Outcome Measures

Primary Outcomes (1)

  • Change in regional myocardial stunning.

    The investigators will use echocardiography to assess the number of left ventricular myocardial segments (using a 18-segment model), that demonstrate a reduction in longitudinal deformation greater than 20% at peak stress during hemodialysis, relative to baseline measurements obtained at the start of the dialysis session. Their aim is to compare changes in regional wall motion abnormalities across three experimental conditions: - Standard hemodialysis (HD-CONT), - Hemodialysis with intradialytic intermittent physical exercise (HD-EX), - Hemodialysis with an intradialytic ischemia/reperfusion sequence applied to the upper limb (HD-RIPC). Patients will participate in all three conditions in a randomized order. A two-week period of standard dialysis will separate the execution of two consecutive sessions.

    From enrollment to the end of treatment at 7 weeks

Secondary Outcomes (91)

  • Hemorheology - blood viscosity

    From enrollment to the end of treatment at 7 weeks

  • Hemorheology - erythrocyte deformability

    From enrollment to the end of treatment at 7 weeks

  • Hemorheology - erythrocyte aggregation

    From enrollment to the end of treatment at 7 weeks

  • Biological data - fibrinogen

    From enrollment to the end of treatment at 7 weeks

  • Biological data - miRNA

    From enrollment to the end of treatment at 7 weeks

  • +86 more secondary outcomes

Study Arms (1)

Patients issued from dialysis units (clinic)

EXPERIMENTAL

Randomised, controlled, crossover, bicentric, single-blind, prospective, open-label, superiority clinical trial comparing 3 dialysis modalities: Procedure A: Standard dialysis Procedure B: Dialysis with intradialytic intermittent physical exercise Procedure C: Dialysis with intradialytic ischaemia/reperfusion sequence of the upper limb Each subject will realize the 3 sessions in a random order.

Other: Remote ischaemic preconditioningOther: ExerciseOther: standard dialysis

Interventions

The dialysis protocol integrates a sequence of five ischaemia/reperfusion blocks applied to the upper limb. Each block consists of a 5-minute period of cuff inflation at a supra-systolic pressure individualized to each patient-20 mmHg above the limb occlusion pressure-followed by a 25-minute period of cuff deflation. This intervention begins 30 minutes after the start of dialysis and is referred to as hemodialysis remote ischaemic preconditioning (HD-rIPC).

Patients issued from dialysis units (clinic)

The exercise protocol consists of five sequential bouts of physical activity, initiated 30 minutes after the start of dialysis. Each bout comprises a 5-minute cycling exercise at moderate intensity, corresponding to a Borg Scale rating of 12-14, followed by a 25-minute passive recovery phase. This structured intervention is referred to as hemodialysis exercise (HD-EX).

Patients issued from dialysis units (clinic)

The hemodialysis control condition (HD-CONT) consists of standard hemodialysis treatment without the integration of any additional interventions, such as exercise or ischaemia/reperfusion protocols.

Patients issued from dialysis units (clinic)

Eligibility Criteria

Age20 Years - 79 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged between 20 and 79 years.
  • Patients on hemodialysis for more than 3 months.
  • No engagement in regular exercise outside of dialysis.
  • No prior exposure to intradialytic exercise within the past six months.
  • No medical contraindications to physical activity.
  • Life expectancy greater than 6 months.
  • Patients with relative good echogenicity

You may not qualify if:

  • Patient is participating in another Category I interventional study, or has participated in another interventional study within the past 3 months
  • The patient is under legal protection or under guardianship or curatorship It turns out to be impossible to give the patient informed information, or the patient refuses to sign the consent
  • Pregnant, parturient or breastfeeding patient
  • Patients with unstable coronary artery disease.
  • Patients with peripheral artery disease (stage III or IV) in the lower limbs.
  • Patients with limb amputation.
  • Patients with musculoskeletal disorders impairing exercise.
  • Presence of a pacemaker, cardiac stimulation device, or implantable cardioverter defibrillator (ICD).
  • History of heart transplant.
  • Patients with uncontrolled hypertension.
  • Refractory anemia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Aider Sante

Montpellier, France

Location

Aider Sante

Nîmes, France

Location

CHU Strasbourg

Strasbourg, France

Location

MeSH Terms

Conditions

Motor ActivityMyocardial Stunning

Interventions

Exercise

Condition Hierarchy (Ancestors)

BehaviorHeart DiseasesCardiovascular DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Laure Patrier, MD, PhD

    AIDER Santé - Fondation Charles Mion

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: All patients are randomly assigned to standard dialysis, dialysis with intermittent intradialytic exercise and dialysis with intermittent remote ischaemic preconditioning.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 5, 2025

First Posted

March 4, 2025

Study Start

February 17, 2025

Primary Completion

June 26, 2025

Study Completion

June 26, 2025

Last Updated

April 29, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations